These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24857827)

  • 1. Effects of selective serotonin reuptake inhibition on neural activity related to risky decisions and monetary rewards in healthy males.
    Macoveanu J; Fisher PM; Haahr ME; Frokjaer VG; Knudsen GM; Siebner HR
    Neuroimage; 2014 Oct; 99():434-42. PubMed ID: 24857827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Playing it safe but losing anyway--serotonergic signaling of negative outcomes in dorsomedial prefrontal cortex in the context of risk-aversion.
    Macoveanu J; Rowe JB; Hornboll B; Elliott R; Paulson OB; Knudsen GM; Siebner HR
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):919-30. PubMed ID: 23051938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered reward processing in the orbitofrontal cortex and hippocampus in healthy first-degree relatives of patients with depression.
    Macoveanu J; Knorr U; Skimminge A; Søndergaard MG; Jørgensen A; Fauerholdt-Jepsen M; Paulson OB; Knudsen GM; Siebner HR; Kessing LV
    Psychol Med; 2014 Apr; 44(6):1183-95. PubMed ID: 23866315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment.
    McCabe C; Mishor Z; Cowen PJ; Harmer CJ
    Biol Psychiatry; 2010 Mar; 67(5):439-45. PubMed ID: 20034615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.
    Epperson CN; Jatlow PI; Czarkowski K; Anderson GM
    Pediatrics; 2003 Nov; 112(5):e425. PubMed ID: 14595087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes.
    Bianchi M; Moser C; Lazzarini C; Vecchiato E; Crespi F
    Exp Brain Res; 2002 Mar; 143(2):191-7. PubMed ID: 11880895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of frontostriatal interaction aligns with reduced primary reward processing under serotonergic drugs.
    Abler B; Grön G; Hartmann A; Metzger C; Walter M
    J Neurosci; 2012 Jan; 32(4):1329-35. PubMed ID: 22279217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neural substrates of probabilistic and intertemporal decision making.
    Weber BJ; Huettel SA
    Brain Res; 2008 Oct; 1234():104-15. PubMed ID: 18710652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Adult 5-HT1A Autoreceptors Results in a Paradoxical Anxiogenic Response to Antidepressant Treatment.
    Turcotte-Cardin V; Vahid-Ansari F; Luckhart C; Daigle M; Geddes SD; Tanaka KF; Hen R; James J; Merali Z; Béïque JC; Albert PR
    J Neurosci; 2019 Feb; 39(8):1334-1346. PubMed ID: 30552180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
    Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
    Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of noradrenergic and serotonergic systems in risk-based decisions between options of equivalent expected value in rats.
    Cui RS; Ruan H; Liu LY; Li XW
    Neurobiol Learn Mem; 2020 Nov; 175():107310. PubMed ID: 32890758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin 2A receptors contribute to the regulation of risk-averse decisions.
    Macoveanu J; Rowe JB; Hornboll B; Elliott R; Paulson OB; Knudsen GM; Siebner HR
    Neuroimage; 2013 Dec; 83():35-44. PubMed ID: 23810974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical substrates of MDMA reward: effects of the inhibition of serotonin reuptake on the acquisition and reinstatement of MDMA-induced CPP.
    Roger-Sánchez C; Aguilar MA; Manzanedo C; Miñarro J; Rodríguez-Arias M
    Curr Pharm Des; 2013; 19(40):7050-64. PubMed ID: 23574442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of 5-HT in response inhibition and re-engagement.
    Drueke B; Schlaegel SM; Seifert A; Moeller O; Gründer G; Gauggel S; Boecker M
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):830-41. PubMed ID: 23816061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonergic modulation of reward and punishment: evidence from pharmacological fMRI studies.
    Macoveanu J
    Brain Res; 2014 Mar; 1556():19-27. PubMed ID: 24508910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Of fish and mirrors: Fluoxetine disrupts aggression and learning for social rewards.
    Eisenreich BR; Greene S; Szalda-Petree A
    Physiol Behav; 2017 May; 173():258-262. PubMed ID: 28237550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine augments the effect of selective serotonin reuptake inhibitors by suppressing GABAergic inhibition via antagonism of 5-HT₆ receptors in the dorsal raphe nucleus.
    Asaoka N; Nagayasu K; Nishitani N; Yamashiro M; Shirakawa H; Nakagawa T; Kaneko S
    Neuropharmacology; 2015 Aug; 95():261-8. PubMed ID: 25863120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverse Effect of Fluoxetine on Medial Prefrontal Cortex Activation During Reward Reversal in ADHD and Autism.
    Chantiluke K; Barrett N; Giampietro V; Brammer M; Simmons A; Murphy DG; Rubia K
    Cereb Cortex; 2015 Jul; 25(7):1757-70. PubMed ID: 24451919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single dose of escitalopram blunts the neural response in the thalamus and caudate during monetary loss.
    Lewis CA; Mueller K; Zsido RG; Reinelt J; Regenthal R; Okon-Singer H; Forbes EE; Villringer A; Sacher J
    J Psychiatry Neurosci; 2021 Apr; 46(3):E319-E327. PubMed ID: 33904667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-week administration of the combined serotonin-noradrenaline reuptake inhibitor duloxetine augments functioning of mesolimbic incentive processing circuits.
    Ossewaarde L; Verkes RJ; Hermans EJ; Kooijman SC; Urner M; Tendolkar I; van Wingen GA; Fernández G
    Biol Psychiatry; 2011 Sep; 70(6):568-74. PubMed ID: 21601833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.